Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding

Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding

Item

http://www.wikidata.org/entity/Q28196728

Q28196728

about

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study.Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS.Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.An automated database case definition for serious bleeding related to oral anticoagulant use.A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC.Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular disease.Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.The clinical impact of bleeding during oral anticoagulant therapy: assessment of morbidity, mortality and post-bleed anticoagulant management.Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review.Novel anticoagulants for atrial fibrillation: a critical appraisal.Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach.Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta-analysis.INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation.Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal.Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).Anticoagulation in women with nonvalvular atrial fibrillation: insights from clinical trials.Major bleeding risk associated with warfarin and co-medications in the elderly population

P2860

Q24633053-18512EDA-D1D6-4A6E-9628-701B7570C9F4 Q28552407-FBCE197F-1979-4710-AEBC-6AC91C7812A1 Q33617751-E20FDFC3-734D-467F-A375-515BFDA19F66 Q33841770-324323AD-1160-434B-9182-585E1276FC46 Q34233473-E5DFD0AB-A99A-4AE8-91F8-E9D8D996AE81 Q34364050-D354F384-AC9F-42DB-9D72-69F8742B0540 Q35016262-3FC2DEC0-884B-4009-AA79-529C90C47823 Q35772034-9E2109FD-8869-4376-959C-EB1A66D7D864 Q36002461-D69CD2EE-1A71-4170-BA8D-D5FF3FF80B84 Q36618123-CF11D67C-D2D9-4189-90E1-B52D116EB347 Q36802592-D64314D9-E053-440A-A743-6D9F2BAE5BEC Q36928194-D9FB303C-BA45-4F7F-829F-39C7D46F2104 Q37823406-8194C8DE-FBD8-4694-908C-73B27EC23F3D Q37890023-6BF4E54D-863B-48ED-8F40-BE020E0C31FF Q37946861-BF9832E9-8B8C-406D-9A77-5C4DCD8EBD20 Q38049617-C91AA614-92C4-4CD2-9108-56B46B919AE6 Q38224507-827A94E4-09D6-46A9-ADBB-CEC1EA145690 Q38525931-1E70B228-C182-4D57-8155-0299F74DD4D8 Q38911940-1D113404-F094-43EB-9E9A-505F84016494 Q39971724-11F17C9F-45ED-4056-9829-FB43DEF68044 Q40456654-F9CDE0C1-365F-42BC-9402-88D9F61D7E8D Q41685100-4DEAEC73-40B6-4C79-AC0C-04C1DBA22333 Q47923995-277E84FF-E60A-49D8-AF58-7647D9F674F2 Q51730417-154685F3-D61B-4321-A885-09B70482CBEF Q57214150-1EF618C1-8BCF-4A22-B767-656D6B398868

P2860

Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding

Item

http://www.wikidata.org/entity/Q28196728

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu